Assembly Biosciences, Inc.
ASMB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $139 | $72 | $104 |
| - Cash | $23 | $24 | $23 | $38 |
| + Debt | $2 | $3 | $3 | $3 |
| Enterprise Value | – | $118 | $51 | $69 |
| Revenue | $11 | $10 | $9 | $7 |
| % Growth | 12.1% | 2.2% | 28% | – |
| Gross Profit | $11 | -$6 | $9 | -$7 |
| % Margin | 100% | -67.5% | 100% | -94.1% |
| EBITDA | -$9 | -$11 | -$10 | -$12 |
| % Margin | -84.9% | -114.9% | -105.2% | -156.3% |
| Net Income | -$9 | -$10 | -$9 | -$10 |
| % Margin | -85.2% | -105.9% | -93.6% | -140.5% |
| EPS Diluted | -1.2 | -1.33 | -1.17 | -1.72 |
| % Growth | 9.8% | -13.7% | 32% | – |
| Operating Cash Flow | -$15 | -$17 | -$23 | -$0 |
| Capital Expenditures | -$0 | $0 | $0 | $0 |
| Free Cash Flow | -$15 | -$17 | -$23 | -$0 |